Skip to content

Eton Pharmaceuticals, Inc. ETON Free cash flow margin

Free cash flow margin at other companies

HRO
HarrowHROW
5.7%+5.0pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-75%-30.5pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-75.1%+10.7pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
20.7%+10.8pp
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-2,321.7%-1,122pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
34.9%-15.2pp

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 9, 2024, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s free cash flow margin?
Eton Pharmaceuticals, Inc. (ETON) reported free cash flow margin of 17.1% in Q1 2024.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.